US Combo Product Designation Appeal Process Refined In Proposed Rule
Executive Summary
In an overhaul of a regulation that sets out how US FDA designates combo products to product centers, the agency is proposing to update its policies so they align with current practices and mandates. FDA is also specifically proposing to streamline a designation appeal process that it says has been a burden for all parties.
You may also be interested in...
FDA Action-Item List Shows Plans To Revamp De Novo, Combo Product, QSR Regs, And More
Planned US FDA actions on the spring 2020 Agency Rule List show expected rules around de novo applications, and combination product classification and appeals – as well as the long-awaited Quality System Regulation overhaul.
Primary-Mode-Of-Action Rule For Combo Products Is Similar To Earlier Draft
FDA's "primary-mode-of-action" 1final rule for combination products largely mirrors the language of last year's proposed version, although the agency adds clarification on various issues raised by stakeholders
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.